Benjamin Beneski
Fortuna: 312 541 $ al 30/09/2026
Fortuna: 312 541 $ al 30/09/2026
Benjamin M.
Beneski currently works at Allogene Therapeutics, Inc., as Chief Technical Officer & Senior Vice President from 2025.
Mr. Beneski received his undergraduate degree from Stevens Institute of Technology and Masters Business Admin degree from Northeastern University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 195.338 ( 0,06 % ) | 312 541 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 28/02/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Stevens Institute of Technology
Stevens Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.